SEC Form 4 · accession 0000914190-15-000297

BIO-TECHNE Corp · TECH

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).

Reporting owner

Officer — Chief Financial Officer

Period of report

Aug 7, 2015

Accepted (ET)

Aug 11, 2015 · 4:43 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000842023

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1	holding	—	—		—	4,434	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (Right to Buy)^F5	$108.49	Aug 7, 2015	A	25,000	A	—	Aug 7, 2022	Common Stock	25,000	25,000	D
Stock Option (Right to Buy)^F7	$108.49	Aug 7, 2015	A	12,500	A	—	Aug 7, 2022	Common Stock	12,500	12,500	D
Restricted Stock Unit^F6,F7	—	Aug 7, 2015	A	2,000	A	—	—	Common Stock	2,000	2,000	D
Stock Option (Right to Buy)^F2	$86.25	holding	—	—	—	—	Apr 1, 2021	Common Stock	25,000	25,000	D
Stock Option (Right to Buy)^F3	$86.25	holding	—	—	—	—	Apr 1, 2021	Common Stock	10,000	10,000	D
Stock Option (Right to Buy)^F4	$94.35	holding	—	—	—	—	Aug 12, 2021	Common Stock	35,000	35,000	D

F1Includes 3,334 shares of restricted stock units that vest 1,667 shares on 3/31/16 and 3/31/17 (previously reported on Table II).
F26,250 shares vest on each of 4/1/15, 4/1/16, 4/1/17 and 4/1/18.
F3Vests in full or in part if certain performance goals are achieved.
F48,750 shares vest on each of 8/12/15, 8/12/16, 8/12/17 and 8/12/18.
F56,250 shares vest on each of 8/7/16, 8/7/17, 8/7/18 and 8/7/19.
F6Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
F7Vests in full or in part if certain performance goals are achieved during each of the 2016, 2017 and 2018 fiscal years.